Aflatoxin exposure is associated with an increased risk of gallbladder cancer.

IF 5.7 2区 医学 Q1 ONCOLOGY
Amit Yadav, Pankaj Gupta, Parikshaa Gupta, Amol N Patil, Chandan K Das, Harish Hooda, Deepa Thakur, Vishal Sharma, Anupam K Singh, Thakur Deen Yadav, Lileswar Kaman, Jarnail Singh Thakur, Hari Kishan Sudini, Radhika Srinivasan, Usha Dutta
{"title":"Aflatoxin exposure is associated with an increased risk of gallbladder cancer.","authors":"Amit Yadav, Pankaj Gupta, Parikshaa Gupta, Amol N Patil, Chandan K Das, Harish Hooda, Deepa Thakur, Vishal Sharma, Anupam K Singh, Thakur Deen Yadav, Lileswar Kaman, Jarnail Singh Thakur, Hari Kishan Sudini, Radhika Srinivasan, Usha Dutta","doi":"10.1002/ijc.35171","DOIUrl":null,"url":null,"abstract":"<p><p>Gall bladder cancer (GBC) is common among the socioeconomically deprived populations of certain geographical regions. Aflatoxin is a genotoxic hepatocarcinogen, which is recognized to have a role in the pathogenesis of hepatocellular carcinoma. However, the role of aflatoxin in the pathogenesis of GBC is largely unknown. We determined serum AFB1-Lys albumin adduct (AAA) levels as a marker of aflatoxin exposure in the patients with GBC and compared to those without GBC. The relationship of AAA levels to cytogenetic (TP53mutation&HER2/neu amplification) and radiological characteristics of the tumor was assessed. We included GBC cases (n = 51) and non-GBC controls (n = 100). Mean serum AAA levels were higher in the GBC group (n = 51) than those without GBC (n = 100) (26.1 ± 12.2 vs. 13.1 ± 11.9 ng/mL; p < .001). HER2/neu expression was associated with higher AAA levels compared to those with equivocal or negative expression (43.9 ± 3 vs. 28.6 ± 10 vs. 19.3 ± 7 ng/mL; p < .001). Older age (age >50 years) (odds ratio [OR] = 3.2 [CI: 1.3-8.2]; p = .013), positive Helicobacter pylori serology (OR = 5.1 [CI: 1.4-17.8]; p = .012), presence of GS (OR = 5 [CI: 1.5-16.9]; p = .009) and detectable AAA levels (OR = 6.8 [CI: 1.3-35.7]; p = .024) were independent risk factors for the presence of the GBC among all study subjects. Among patients harboring GS, older age (age >50 years) (OR = 4.5 [CI: 1.3-14.9]; p = .015), female gender (OR = 3.8 [CI: 1.2-12.5]; p = .027), presence of multiple GS (OR = 21.9 [CI: 4.8-100.4]; p < .001) and high serum AAA levels (OR = 5.3 [CI: 1.6-17.3]; p = .006) were independent risk factors for the presence of the GBC. Elderly age >50 years (OR = 2.6 [CI: 1.3-5.2]; p = .010) and frequent peanut consumption (OR = 2.3 [CI: 1.1-4.9]; p = .030) were independent risk factors for high serum AAA levels. The current study has implications for the prevention of GBC through the reduction of dietary aflatoxin exposure.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":null,"pages":null},"PeriodicalIF":5.7000,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ijc.35171","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Gall bladder cancer (GBC) is common among the socioeconomically deprived populations of certain geographical regions. Aflatoxin is a genotoxic hepatocarcinogen, which is recognized to have a role in the pathogenesis of hepatocellular carcinoma. However, the role of aflatoxin in the pathogenesis of GBC is largely unknown. We determined serum AFB1-Lys albumin adduct (AAA) levels as a marker of aflatoxin exposure in the patients with GBC and compared to those without GBC. The relationship of AAA levels to cytogenetic (TP53mutation&HER2/neu amplification) and radiological characteristics of the tumor was assessed. We included GBC cases (n = 51) and non-GBC controls (n = 100). Mean serum AAA levels were higher in the GBC group (n = 51) than those without GBC (n = 100) (26.1 ± 12.2 vs. 13.1 ± 11.9 ng/mL; p < .001). HER2/neu expression was associated with higher AAA levels compared to those with equivocal or negative expression (43.9 ± 3 vs. 28.6 ± 10 vs. 19.3 ± 7 ng/mL; p < .001). Older age (age >50 years) (odds ratio [OR] = 3.2 [CI: 1.3-8.2]; p = .013), positive Helicobacter pylori serology (OR = 5.1 [CI: 1.4-17.8]; p = .012), presence of GS (OR = 5 [CI: 1.5-16.9]; p = .009) and detectable AAA levels (OR = 6.8 [CI: 1.3-35.7]; p = .024) were independent risk factors for the presence of the GBC among all study subjects. Among patients harboring GS, older age (age >50 years) (OR = 4.5 [CI: 1.3-14.9]; p = .015), female gender (OR = 3.8 [CI: 1.2-12.5]; p = .027), presence of multiple GS (OR = 21.9 [CI: 4.8-100.4]; p < .001) and high serum AAA levels (OR = 5.3 [CI: 1.6-17.3]; p = .006) were independent risk factors for the presence of the GBC. Elderly age >50 years (OR = 2.6 [CI: 1.3-5.2]; p = .010) and frequent peanut consumption (OR = 2.3 [CI: 1.1-4.9]; p = .030) were independent risk factors for high serum AAA levels. The current study has implications for the prevention of GBC through the reduction of dietary aflatoxin exposure.

接触黄曲霉毒素会增加患胆囊癌的风险。
胆囊癌(GBC)在某些地区的社会经济贫困人口中很常见。黄曲霉毒素是一种具有基因毒性的肝致癌物质,被认为在肝细胞癌的发病机制中发挥作用。然而,黄曲霉毒素在肝细胞癌发病机制中的作用在很大程度上还不为人所知。我们测定了 GBC 患者的血清 AFB1-赖氨酸白蛋白加合物(AAA)水平,作为黄曲霉毒素暴露的标志物,并与非 GBC 患者进行了比较。我们还评估了AAA水平与肿瘤的细胞遗传学(TP53突变&HER2/neu扩增)和放射学特征之间的关系。我们纳入了 GBC 病例(n = 51)和非 GBC 对照组(n = 100)。GBC组(n = 51)的平均血清AAA水平高于非GBC组(n = 100)(26.1 ± 12.2 vs. 13.1 ± 11.9 ng/mL;p 50岁)(几率比[OR] = 3.2 [CI:1.3-8.2];p = .013),幽门螺旋杆菌血清学阳性(OR = 5.1 [CI:1.4-17.8];p = .012)、GS(OR = 5 [CI:1.5-16.9];p = .009)和可检测到的 AAA 水平(OR = 6.8 [CI:1.3-35.7];p = .024)是所有研究对象中出现 GBC 的独立危险因素。在携带 GS 的患者中,年龄较大(年龄大于 50 岁)(OR = 4.5 [CI:1.3-14.9];P = .015)、女性(OR = 3.8 [CI:1.2-12.5];P = .027)、存在多个 GS(OR = 21.9 [CI:4.8-100.4]; p 50 岁 (OR = 2.6 [CI: 1.3-5.2]; p = .010) 和经常食用花生 (OR = 2.3 [CI: 1.1-4.9]; p = .030) 是血清 AAA 水平高的独立危险因素。本研究对通过减少膳食中黄曲霉毒素的摄入量来预防GBC具有重要意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信